• Home
  • News
  • Australian Drug Trends 2020: Key Findings from the National Ecstasy and Related Drugs Reporting System (EDRS) Interviews

Australian Drug Trends 2020: Key Findings from the National Ecstasy and Related Drugs Reporting System (EDRS) Interviews

Nov 13, 2020

Each year the National Drug and Alcohol Research Centre (NDARC) produce the Australian Drug Trends research, which tracks the price, purity and availability of a range of different drugs. The Ecstasy and Related Drugs Reporting System (EDRS) has just published the findings from the 2020 interviews with regular ecstasy users from across Australia. 

This piece of research interviews people who use ecstasy and other related drugs and asks specifics in relation to those substances such as frequency of use, amount used, the cost of substances and more.  In 2020 the survey was taken during April to July, showing us some of the key trends in the way COVID-19 has affected substance use in Australia. Some of the key findings include: 

  • Overall perceived decrease of substances since March 2020 including MDMA/ecstasy, cocaine and ketamine; 
  • Decreasing use of ecstasy in pill form, with capsules now the most common form of ecstasy
  • Continuing decline in the price of crystal MDMA, with a gram now reported as costing $150, compared with $200 per gram in 2018.

Go to “Australian Drug Trends 2020: Key Findings from the National Ecstasy and Related Drugs Reporting System (EDRS) Interviews”